Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
As of close of business last night, BioAge Labs Inc’s stock clocked out at $5.82, up 4.68% from its previous closing price of $5.56. In other words, the price has increased by $4.68 from its previous closing price. On the day, 0.85 million shares were traded. BIOA stock price reached its highest trading level at $6.0 during the session, while it also had its lowest trading level at $5.5.
Ratios:
To gain a deeper understanding of BIOA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 17.63 and its Current Ratio is at 17.63. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Morgan Stanley on December 10, 2024, Downgraded its rating to Underweight and sets its target price to $5 from $40 previously.
On December 09, 2024, Jefferies Downgraded its rating to Hold which previously was Buy and also lowered its target price recommendation from $42 to $7.
Citigroup Downgraded its Buy to Neutral on December 09, 2024, whereas the target price for the stock was revised from $45 to $7.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Oct 01 ’24 when Pande Vijay Satyanand bought 126,793 shares for $19.73 per share. The transaction valued at 2,501,626 led to the insider holds 1,026,793 shares of the business.
Pande Vijay Satyanand bought 67,096 shares of BIOA for $1,323,804 on Oct 02 ’24. The Director now owns 1,093,889 shares after completing the transaction at $19.73 per share. On Oct 03 ’24, another insider, Pande Vijay Satyanand, who serves as the Director of the company, bought 25,306 shares for $19.90 each. As a result, the insider paid 503,589 and bolstered with 1,119,195 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BIOA now has a Market Capitalization of 208639440 and an Enterprise Value of -125235504.
Stock Price History:
Over the past 52 weeks, BIOA has reached a high of $26.62, while it has fallen to a 52-week low of $3.85. The 50-Day Moving Average of the stock is -61.52%, while the 200-Day Moving Average is calculated to be -65.82%.
Shares Statistics:
It appears that BIOA traded 747.80K shares on average per day over the past three months and 1159910 shares per day over the past ten days. A total of 34.20M shares are outstanding, with a floating share count of 20.46M. Insiders hold about 42.93% of the company’s shares, while institutions hold 32.48% stake in the company. Shares short for BIOA as of 1734048000 were 1351161 with a Short Ratio of 1.81, compared to 1731628800 on 2372884.
